1. Market Research
  2. > Business Services
  3. > Research and Development Market Trends
  4. > Hutchison MediPharma Limited - Product Pipeline Review - 2015

Hutchison MediPharma Limited - Product Pipeline Review - 2015

  • August 2015
  • -
  • Global Markets Direct
  • -
  • 49 pages

Hutchison MediPharma Limited - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Hutchison MediPharma Limited - Product Pipeline Review - 2015’, provides an overview of the Hutchison MediPharma Limited’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Hutchison MediPharma Limited’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Hutchison MediPharma Limited including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Hutchison MediPharma Limited’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Hutchison MediPharma Limited’s pipeline products

Reasons to buy

- Evaluate Hutchison MediPharma Limited’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Hutchison MediPharma Limited in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Hutchison MediPharma Limited’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Hutchison MediPharma Limited and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Hutchison MediPharma Limited
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Hutchison MediPharma Limited and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table Of Contents

Hutchison MediPharma Limited - Product Pipeline Review - 2015
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
Hutchison MediPharma Limited Snapshot 6
Hutchison MediPharma Limited Overview 6
Key Information 6
Key Facts 6
Hutchison MediPharma Limited - Research and Development Overview 7
Key Therapeutic Areas 7
Hutchison MediPharma Limited - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Hutchison MediPharma Limited - Pipeline Products Glance 12
Hutchison MediPharma Limited - Late Stage Pipeline Products 12
Phase III Products/Combination Treatment Modalities 12
Hutchison MediPharma Limited - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Hutchison MediPharma Limited - Early Stage Pipeline Products 15
IND/CTA Filed Products/Combination Treatment Modalities 15
Preclinical Products/Combination Treatment Modalities 16
Discovery Products/Combination Treatment Modalities 17
Hutchison MediPharma Limited - Drug Profiles 18
HMPL-013 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
HMPL-504 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
HMPL-012 22
Product Description 22
Mechanism of Action 22
RandD Progress 22
HMPL-309 24
Product Description 24
Mechanism of Action 24
RandD Progress 24
HMPL-523 25
Product Description 25
Mechanism of Action 25
RandD Progress 25
HMPL-813 26
Product Description 26
Mechanism of Action 26
RandD Progress 26
HM-029 27
Product Description 27
Mechanism of Action 27
RandD Progress 27
HM-032 28
Product Description 28
Mechanism of Action 28
RandD Progress 28
HM-5016699 29
Product Description 29
Mechanism of Action 29
RandD Progress 29
HMPL-453 30
Product Description 30
Mechanism of Action 30
RandD Progress 30
HMPL-507 31
Product Description 31
Mechanism of Action 31
RandD Progress 31
HMPL-689 32
Product Description 32
Mechanism of Action 32
RandD Progress 32
HMPL-518 33
Product Description 33
Mechanism of Action 33
RandD Progress 33
Hutchison MediPharma Limited - Pipeline Analysis 34
Hutchison MediPharma Limited - Pipeline Products by Target 34
Hutchison MediPharma Limited - Pipeline Products by Route of Administration 36
Hutchison MediPharma Limited - Pipeline Products by Molecule Type 37
Hutchison MediPharma Limited - Pipeline Products by Mechanism of Action 38
Hutchison MediPharma Limited - Recent Pipeline Updates 40
Hutchison MediPharma Limited - Dormant Projects 46
Hutchison MediPharma Limited - Locations And Subsidiaries 47
Head Office 47
Other Locations and Subsidiaries 47
Appendix 48
Methodology 48
Coverage 48
Secondary Research 48
Primary Research 48
Expert Panel Validation 48
Contact Us 48
Disclaimer 49

List of Tables
Hutchison MediPharma Limited, Key Information 6
Hutchison MediPharma Limited, Key Facts 6
Hutchison MediPharma Limited - Pipeline by Indication, 2015 8
Hutchison MediPharma Limited - Pipeline by Stage of Development, 2015 10
Hutchison MediPharma Limited - Monotherapy Products in Pipeline, 2015 11
Hutchison MediPharma Limited - Phase III, 2015 12
Hutchison MediPharma Limited - Phase II, 2015 13
Hutchison MediPharma Limited - Phase I, 2015 14
Hutchison MediPharma Limited - IND/CTA Filed, 2015 15
Hutchison MediPharma Limited - Preclinical, 2015 16
Hutchison MediPharma Limited - Discovery, 2015 17
Hutchison MediPharma Limited - Pipeline by Target, 2015 34
Hutchison MediPharma Limited - Pipeline by Route of Administration, 2015 36
Hutchison MediPharma Limited - Pipeline by Molecule Type, 2015 37
Hutchison MediPharma Limited - Pipeline Products by Mechanism of Action, 2015 39
Hutchison MediPharma Limited - Recent Pipeline Updates, 2015 40
Hutchison MediPharma Limited - Dormant Developmental Projects,2015 46
Hutchison MediPharma Limited, Other Locations 47

List of Figures
Hutchison MediPharma Limited - Pipeline by Top 10 Indication, 2015 8
Hutchison MediPharma Limited - Pipeline by Stage of Development, 2015 10
Hutchison MediPharma Limited - Monotherapy Products in Pipeline, 2015 11
Hutchison MediPharma Limited - Pipeline by Top 10 Target, 2015 34
Hutchison MediPharma Limited - Pipeline by Top 10 Route of Administration, 2015 36
Hutchison MediPharma Limited - Pipeline by Top 10 Molecule Type, 2015 37
Hutchison MediPharma Limited - Pipeline Products by Top 10 Mechanism of Action, 2015 38

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016

Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Integrin Alpha 7 (ITGA7) - Pipeline Review, H2 2016’, provides in depth analysis on Integrin Alpha 7 (ITGA7) ...

Pulmonary Fibrosis - Pipeline Review, H2 2016

Pulmonary Fibrosis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Pulmonary Fibrosis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Pulmonary Fibrosis - Pipeline Review, H2 2016’, provides an overview of the Pulmonary Fibrosis pipeline landscape. ...

Cognitive Impairment - Pipeline Review, H2 2016

Cognitive Impairment - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • September 2016
  • by Global Markets Direct

Cognitive Impairment - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H2 2016’, provides an overview of the Cognitive Impairment pipeline landscape. ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.